Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald L Denardo

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Cancer|March 6, 2002
Combined modality radioimmunotherapy. Promise and perilPatricia A Burke, Sally J DeNardo, Laird A Miers, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibodySui Shen, Gerald L DeNardo, Aina Yuan, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissuesChristine L Hartmann Siantar, Gerald L DeNardo, Kit Lam, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2008
Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapyArutselvan Natarajan, Pappanaicken R Kumaresan, Sally J Denardo, et al.
Chemical Communications (Cambridge, England)|March 30, 2007
Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloadditionArutselvan Natarajan, Wenjun Du, Cheng-Yi Xiong, et al.
Cancer Research|August 3, 2002
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenograftsPatricia A Burke, Sally J DeNardo, Laird A Miers, et al.
Bioconjugate Chemistry|January 22, 2004
Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demandHuguette Albrecht, Patricia A Burke, Arutselvan Natarajan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancerJoerg Lehmann, Gerald L DeNardo, Aina Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Characterization of human IgG antimouse antibody in patients with B-cell malignanciesGerald L DeNardo, Gary R Mirick, Linda A Kroger, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2006
Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignanciesIgnacio Azinovic, Gerald L DeNardo, Kathleen R Lamborn, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Cancer|March 6, 2002
Combined modality radioimmunotherapy. Promise and perilPatricia A Burke, Sally J DeNardo, Laird A Miers, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2006
Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibodySui Shen, Gerald L DeNardo, Aina Yuan, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissuesChristine L Hartmann Siantar, Gerald L DeNardo, Kit Lam, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2008
Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapyArutselvan Natarajan, Pappanaicken R Kumaresan, Sally J Denardo, et al.
Chemical Communications (Cambridge, England)|March 30, 2007
Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloadditionArutselvan Natarajan, Wenjun Du, Cheng-Yi Xiong, et al.
Cancer Research|August 3, 2002
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenograftsPatricia A Burke, Sally J DeNardo, Laird A Miers, et al.
Bioconjugate Chemistry|January 22, 2004
Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demandHuguette Albrecht, Patricia A Burke, Arutselvan Natarajan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancerJoerg Lehmann, Gerald L DeNardo, Aina Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Characterization of human IgG antimouse antibody in patients with B-cell malignanciesGerald L DeNardo, Gary R Mirick, Linda A Kroger, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2006
Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignanciesIgnacio Azinovic, Gerald L DeNardo, Kathleen R Lamborn, et al.
Pageof 7